Huntington Disease Treatments
Find Huntington Disease Treatments
Brand Name
Xenazine
Generic Name
Tetrabenazine
View Brand Information FDA approval date: November 24, 2008
Classification: Vesicular Monoamine Transporter 2 Inhibitor
Form: Tablet
What is Xenazine (Tetrabenazine)?
XENAZINE is indicated for the treatment of chorea associated with Huntington’s disease. XENAZINE is a vesicular monoamine transporter 2 inhibitor indicated for the treatment of chorea associated with Huntington’s disease.
Top Global Experts
Save this treatment for later
Not sure about your diagnosis?
Tired of the same old research?
Related Clinical Trials
There is no clinical trials being done for this treatment